DH Stock Analysis: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$0.71
-0.01 (-1.84%)
âŧ
5d:
+11.72%
30d:
+4.11%
90d:
-12.93%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: DH is fairly priced but lacks strong directional signals. At -14.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: DH is fairly priced but lacks strong directional signals. At -14.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $0.71, which is considered fair relative to its 30-day fair value range of $0.65 to $0.76. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.8) compared to its historical average (6.1). Remarkably, the market is currently pricing in an annual earnings decline of 14.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $0.61, while resistance sits at $0.75.
Market Sentiment: DH scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.70 (+138.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $0.61, while resistance sits at $0.75.
Market Sentiment: DH scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.70 (+138.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.65 -
$0.76
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (69/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 138.1% below Wall St target ($1.70)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.65 -
$0.76
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.61
Resistance Level
$0.75
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.82
Wall Street Target
$1.70
(+138.1%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-72.3%
Valuation Discount vs History
-14.5% cheaper
PE vs Historical
3.8 vs 6.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.5%
(market-implied from PE analysis)
1-Year Target
$0.64
(-10%)
2-Year Target
$0.58
(-19%)
3-Year Target
$0.52
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4â6)
$0.83
(+17%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: -4.7%)
$3.24
(+354%)
Base:
(SPY PE: 3.8, Growth: -4.7%)
$0.62
(-14%)
Bear:
(PE: 3.2, Growth: -4.7%)
$0.52
(-27%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.8 to 6.1
Stabilization Target:
$1.14
(+59.7%)
PE Expansion Potential:
+59.7%
Share & Embed Analysis
Last updated: August 22, 2026 1:58 PM ET
Data refreshes hourly during market hours. Next update: 2:58 PM
Data refreshes hourly during market hours. Next update: 2:58 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
12 analysts |
$79 | 63 BUY |
